Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Skeletal Radiology
Published in: Skeletal Radiology 8/2012

01-08-2012 | Review Article

Advanced imaging of skeletal manifestations of systemic mastocytosis

Authors: J. Fritz, E. K. Fishman, J. A. Carrino, M. S. Horger

Published in: Skeletal Radiology | Issue 8/2012

Login to get access

Abstract

Systemic mastocytosis comprises a group of clonal disorders of the mast cell that most commonly involves the skeletal system. Imaging can be helpful in the detection and characterization of the osseous manifestations of this disease. While radiography and bone scans are frequently used for this assessment, low-dose multidetector computed tomography and magnetic resonance imaging can be more sensitive for the detection of marrow involvement and for the demonstration of the various disease patterns. In this article, we review the pathophysiological and clinical features of systemic mastocytosis, discuss the role of imaging for staging and management, and illustrate the various cross-sectional imaging appearances. Awareness and knowledge of the imaging features of this disorder will increase the accuracy of image interpretation and can contribute important information for management decisions.
Literature
1.
Kirshenbaum AS, Goff JP, Semere T, Foster B, Scott LM, Metcalfe DD. Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13). Blood. 1999;94:2333–42.PubMed
2.
3.
Horny H, Metcalfe D, Bennett J, Bain B, Akin C, Escribano L. Mastocytosis. In: Swerdlow S, Campo E, Harris N, editors. WHO classification of tumors of hematopoietic and lymphoid tissues. Lyon: IARC Press; 2008. p. 54–63.
4.
Valent P, Sperr WR, Schwartz LB, Horny HP. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms. J Allergy Clin Immunol. 2004;114:3–11.PubMedCrossRef
5.
Murali MR, Castells MC, Song JY, Dudzinski DM, Hasserjian RP. Case records of the Massachusetts General Hospital. Case 9-2011. A 37-year-old man with flushing and hypotension. N Engl J Med. 2011;364:1155–65.PubMedCrossRef
6.
Zanotti R, Bonadonna P, Bonifacio M, Artuso A, Schena D, Rossini M, et al. Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis. Haematologica. 2011;96:482–4.PubMedCrossRef
7.
Simpson JK, Metcalfe DD. Mastocytosis and disorders of mast cell proliferation. Clin Rev Allergy Immunol. 2002;22:175–88.PubMedCrossRef
8.
9.
Travis WD, Li CY, Bergstralh EJ, Yam LT, Swee RG. Systemic mast cell disease. Analysis of 58 cases and literature review. Medicine (Baltimore). 1988;67:345–68.
10.
Genovese A, Spadaro G, Triggiani M, Marone G. Clinical advances in mastocytosis. Int J Clin Lab Res. 1995;25:178–88.PubMedCrossRef
11.
Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001;25:603–25.PubMedCrossRef
12.
Pardanani A, Lim KH, Lasho TL, Finke C, McClure RF, Li CY, et al. Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies. Blood. 2009;114:3769–72.PubMedCrossRef
13.
Parker RI. Hematologic aspects of systemic mastocytosis. Hematol Oncol Clin North Am. 2000;14:557–68.PubMedCrossRef
14.
Lim KH, Tefferi A, Lasho TL, Finke C, Patnaik M, Butterfield JH, et al. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood. 2009;113:5727–36.PubMedCrossRef
15.
Barete S, Assous N, de Gennes C, Grandpeix C, Feger F, Palmerini F, et al. Systemic mastocytosis and bone involvement in a cohort of 75 patients. Ann Rheum Dis. 2010;69:1838–41.PubMedCrossRef
16.
Lawrence JB, Friedman BS, Travis WD, Chinchilli VM, Metcalfe DD, Gralnick HR. Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis. Am J Med. 1991;91:612–24.PubMedCrossRef
17.
Johansson C, Roupe G, Lindstedt G, Mellstrom D. Bone density, bone markers and bone radiological features in mastocytosis. Age Ageing. 1996;25:1–7.PubMedCrossRef
18.
Rafii M, Firooznia H, Golimbu C, Balthazar E. Pathologic fracture in systemic mastocytosis. Radiographic spectrum and review of the literature. Clin Orthop Relat Res. 1983;260–7.
19.
Rosenbaum RC, Frieri M, Metcalfe DD. Patterns of skeletal scintigraphy and their relationship to plasma and urinary histamine levels in systemic mastocytosis. J Nucl Med. 1984;25:859–64.PubMed
20.
Goldhaber P. Heparin enhancement of factors stimulating bone resorption in tissue culture. Science. 1965;147:407–8.PubMedCrossRef
21.
22.
Gospodarowicz D, Cheng J. Heparin protects basic and acidic FGF from inactivation. J Cell Physiol. 1986;128:475–84.PubMedCrossRef
23.
McKenna MJ, Frame B. The mast cell and bone. Clin Orthop Relat Res. 1985;226–33.
24.
Resnick D, Haghishi P. Lymphoproliferative and myeloproliferative disorders. In: Resnick D, editor. Diagnosis of bone and joint disorders. Philadelphia: Saunders; 2002. p. 2327–31.
25.
Floman Y, Amir G. Systemic mastocytosis presenting with severe spinal osteopenia and multiple compression fractures. J Spinal Disord. 1991;4:369–73.PubMedCrossRef
26.
27.
Sundaram M. Founders lecture 2007: Metabolic bone disease: what has changed in 30 years? Skeletal Radiol. 2009;38:841–53.PubMedCrossRef
28.
Link TM. The Founder’s Lecture 2009: advances in imaging of osteoporosis and osteoarthritis. Skeletal Radiol. 2010;39:943–55.PubMedCrossRef
29.
Ejindu VC, Hine AL, Mashayekhi M, Shorvon PJ, Misra RR. Musculoskeletal manifestations of sickle cell disease. Radiographics. 2007;27:1005–21.PubMedCrossRef
30.
Katz R, Booth T, Hargunani R, Wylie P, Holloway B. Radiological aspects of Gaucher disease. Skeletal Radiol. 2011;40:1505–13.PubMedCrossRef
31.
Sebes JI, Niell HB, Palmieri GM, Reidy TJ. Skeletal surveys in multiple myeloma. Radiologic-clinical correlation. Skeletal Radiol. 1986;15:354–9.PubMedCrossRef
32.
Horger M, Kanz L, Denecke B, Vonthein R, Pereira P, Claussen CD, et al. The benefit of using whole-body, low-dose, nonenhanced, multidetector computed tomography for follow-up and therapy response monitoring in patients with multiple myeloma. Cancer. 2007;109:1617–26.PubMedCrossRef
33.
Tunaci M, Tunaci A, Engin G, Ozkorkmaz B, Dincol G, Acunas G, et al. Imaging features of thalassemia. Eur Radiol. 1999;9:1804–9.PubMedCrossRef
34.
Bieler EU, Wohlenberg H, Utech C. Skeletal manifestations of generalized mastocytosis in the skeletal scintigram compared with roentgen findings. Rofo. 1985;142:552–8.PubMedCrossRef
35.
Huang TY, Yam LT, Li CY. Radiological features of systemic mast-cell disease. Br J Radiol. 1987;60:765–70.PubMedCrossRef
36.
Bancroft LW, Berquist TH. Erdheim-Chester disease: radiographic findings in five patients. Skeletal Radiol. 1998;27:127–32.PubMedCrossRef
37.
Baskin Jr HJ. The pathogenesis and imaging of the tuberous sclerosis complex. Pediatr Radiol. 2008;38:936–52.PubMedCrossRef
38.
Guermazi A, de Kerviller E, Cazals-Hatem D, Zagdanski AM, Frija J. Imaging findings in patients with myelofibrosis. Eur Radiol. 1999;9:1366–75.PubMedCrossRef
39.
Mithal A, Trivedi N, Gupta SK, Kumar S, Gupta RK. Radiological spectrum of endemic fluorosis: relationship with calcium intake. Skeletal Radiol. 1993;22:257–61.PubMedCrossRef
40.
Mirra JM, Brien EW, Tehranzadeh J. Paget’s disease of bone: review with emphasis on radiologic features. II. Skeletal Radiol. 1995;24:173–84.PubMed
41.
Mirra JM, Brien EW, Tehranzadeh J. Paget’s disease of bone: review with emphasis on radiologic features. I. Skeletal Radiol. 1995;24:163–71.PubMed
42.
Burgener FA, Perry PE. Solitary renal cell carcinoma metastasis in Paget’s disease simulating sarcomatous degeneration. AJR Am J Roentgenol. 1977;128:853–5.PubMed
43.
Dell’Atti C, Cassar-Pullicino VN, Lalam RK, Tins BJ, Tyrrell PN. The spine in Paget’s disease. Skeletal Radiol. 2007;36:609–26.PubMedCrossRef
44.
45.
Graves III L, Stechschulte DJ, Morris DC, Lukert BP. Inhibition of mediator release in systemic mastocytosis is associated with reversal of bone changes. J Bone Miner Res. 1990;5:1113–9.PubMedCrossRef
46.
Chen CC, Andrich MP, Mican JM, Metcalfe DD. A retrospective analysis of bone scan abnormalities in mastocytosis: correlation with disease category and prognosis. J Nucl Med. 1994;35:1471–5.PubMed
47.
Ho LM, Lipper MH. Mastocytosis of the axial skeleton presenting as an epidural mass lesion: MR imaging appearance. AJR Am J Roentgenol. 1996;167:716–8.PubMed
48.
Gleeson TG, Moriarty J, Shortt CP, Gleeson JP, Fitzpatrick P, Byrne B, et al. Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI). Skeletal Radiol. 2009;38:225–36.PubMedCrossRef
49.
Kropil P, Fenk R, Fritz LB, Blondin D, Kobbe G, Modder U, et al. Comparison of whole-body 64-slice multidetector computed tomography and conventional radiography in staging of multiple myeloma. Eur Radiol. 2008;18:51–8.PubMedCrossRef
50.
Mahnken AH, Wildberger JE, Gehbauer G, Schmitz-Rode T, Blaum M, Fabry U, et al. Multidetector CT of the spine in multiple myeloma: comparison with MR imaging and radiography. AJR Am J Roentgenol. 2002;178:1429–36.PubMed
51.
Avila NA, Ling A, Metcalfe DD, Worobec AS. Mastocytosis: magnetic resonance imaging patterns of marrow disease. Skeletal Radiol. 1998;27:119–26.PubMedCrossRef
52.
Avila NA, Ling A, Worobec AS, Mican JM, Metcalfe DD. Systemic mastocytosis: CT and US features of abdominal manifestations. Radiology. 1997;202:367–72.PubMed
53.
Horger M, Claussen CD, Bross-Bach U, Vonthein R, Trabold T, Heuschmid M, et al. Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography. Eur J Radiol. 2005;54:289–97.PubMedCrossRef
54.
Roca M, Mota J, Giraldo P, Garcia Erce JA. Systemic mastocytosis: MRI of bone marrow involvement. Eur Radiol. 1999;9:1094–7.PubMedCrossRef
55.
Haney K, Russell W, Raila FA, Brower AC, Harrison RB. MRI characteristics of systemic mastocytosis of the lumbosacral spine. Skeletal Radiol. 1996;25:171–3.PubMedCrossRef
56.
Hwang S, Panicek DM. Magnetic resonance imaging of bone marrow in oncology. I. Skeletal Radiol. 2007;36:913–20.PubMedCrossRef
57.
Khoo MM, Tyler PA, Saifuddin A, Padhani AR. Diffusion-weighted imaging (DWI) in musculoskeletal MRI: a critical review. Skeletal Radiol. 2011;40:665–81.PubMedCrossRef
58.
Bartuseviciene A, Samuilis A, Skucas J. Camurati-Engelmann disease: imaging, clinical features and differential diagnosis. Skeletal Radiol. 2009;38:1037–43.PubMedCrossRef
59.
Schmidt GP, Reiser MF, Baur-Melnyk A. Whole-body imaging of the musculoskeletal system: the value of MR imaging. Skeletal Radiol. 2007;36:1109–19.PubMedCrossRef
60.
Chavhan GB, Babyn PS. Whole-body MR imaging in children: principles, technique, current applications, and future directions. Radiographics. 2011;31:1757–72.PubMedCrossRef
61.
Bauerle T, Hillengass J, Fechtner K, Zechmann CM, Grenacher L, Moehler TM, et al. Multiple myeloma and monoclonal gammopathy of undetermined significance: importance of whole-body versus spinal MR imaging. Radiology. 2009;252:477–85.PubMedCrossRef
62.
Zettinig G, Becherer A, Szabo M, Uffmann M, Dudczak R, Valent P, et al. FDG positron emission tomography in patients with systemic mastocytosis. AJR Am J Roentgenol. 2002;179:1235–7.PubMed
63.
Tomihama RT, McEachen JC, Kuo PH. Imaging of systemic mastocytosis by FDG-PET/CT demonstrates increased activity in cortical bone. Clin Nucl Med. 2008;33:220–3.PubMedCrossRef
Metadata
Title
Advanced imaging of skeletal manifestations of systemic mastocytosis
Authors
J. Fritz
E. K. Fishman
J. A. Carrino
M. S. Horger
Publication date
01-08-2012
Publisher
Springer-Verlag
Published in
Skeletal Radiology / Issue 8/2012
Print ISSN: 0364-2348
Electronic ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-012-1374-9

Other articles of this Issue 8/2012

Skeletal Radiology 8/2012 Go to the issue

Case Report

Bilateral synchronous tibial periosteal osteosarcoma with familial incidence

Scientific Article

Cone-beam computed tomography arthrography: an innovative modality for the evaluation of wrist ligament and cartilage injuries

Case Report

Case report: periosteal osteosarcoma of the clavicle

Scientific Article

Skeletal muscle metastases: a three-part study of a not-so-rare entity

Case Report

Aspergillus osteomyelitis of the proximal humerus: a case report

Case Report

Intra-articular extraskeletal myxoid chondrosarcoma of the ankle